SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLS.L Regulatory News (SLS)

  • There is currently no data for SLS

Increased Loan Facility

11 May 2021 09:09

RNS Number : 2123Y
Standard Life UK Small.Co's Tst PLC
11 May 2021
 

STANDARD LIFE UK SMALLER COMPANIES TRUST PLC (the "Company")

Legal Entity Identifier (LEI): 213800UUKA68SHSJBE37

 

 

11 May 2021

 

Increased Loan Facility

 

The Company is pleased to announce that it has amended its loan agreement with The Royal Bank of Scotland International Limited ("RBSI") to provide it with an additional ÂŁ20 million revolving credit facility ("RCF"). Together with the existing RBSI loan facility, this means that the Company's borrowing facilities now amount to ÂŁ65 million in aggregate, comprising a ÂŁ25 million fixed-rate loan, at an interest rate 2.349%, and a ÂŁ40 million RCF. The entire facility is due to mature on 31 October 2022.

 

 

 

Enquiries:

 

Evan Bruce-Gardyne, Aberdeen Standard Investments, 07720 073216

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFASAFEFSESI
Date   Source Headline
23rd Jul 20199:17 amRNSPortfolio Valuation
22nd Jul 201911:01 amRNSNet Asset Value(s)
19th Jul 201910:16 amRNSNet Asset Value(s)
18th Jul 201910:20 amRNSNet Asset Value(s)
17th Jul 201910:16 amRNSNet Asset Value(s)
16th Jul 201910:43 amRNSNet Asset Value(s)
15th Jul 20199:28 amRNSNet Asset Value(s)
12th Jul 201910:03 amRNSNet Asset Value(s)
11th Jul 20199:52 amRNSNet Asset Value(s)
10th Jul 20191:14 pmRNSHolding(s) in Company
10th Jul 201910:05 amRNSNet Asset Value(s)
9th Jul 201910:06 amRNSNet Asset Value(s)
8th Jul 201911:01 amRNSNet Asset Value(s)
5th Jul 201910:25 amRNSNet Asset Value(s)
4th Jul 201910:51 amRNSNet Asset Value(s)
3rd Jul 20194:49 pmRNSCompliance with MAR
3rd Jul 20194:41 pmRNSMonth End Net Asset Values
3rd Jul 201911:07 amRNSNet Asset Value(s)
2nd Jul 201911:49 amRNSQuarterly Disclosure
2nd Jul 201910:18 amRNSNet Asset Value(s)
28th Jun 20199:58 amRNSNet Asset Value(s)
27th Jun 201911:47 amRNSNet Asset Value(s)
26th Jun 201910:50 amRNSNet Asset Value(s)
25th Jun 201911:24 amRNSNet Asset Value(s)
25th Jun 20199:37 amRNSNet Asset Value(s)
21st Jun 20193:30 pmRNSPortfolio Valuation
21st Jun 20193:23 pmRNSMonthly Factsheet
21st Jun 20199:52 amRNSNet Asset Value(s)
20th Jun 20199:42 amRNSNet Asset Value(s)
19th Jun 201910:34 amRNSNet Asset Value(s)
18th Jun 201910:28 amRNSNet Asset Value(s)
17th Jun 201910:33 amRNSNet Asset Value(s)
14th Jun 201910:13 amRNSNet Asset Value(s)
13th Jun 201910:21 amRNSNet Asset Value(s)
12th Jun 201910:51 amRNSNet Asset Value(s)
11th Jun 201910:28 amRNSNet Asset Value(s)
10th Jun 201911:14 amRNSNet Asset Value(s)
7th Jun 201910:41 amRNSNet Asset Value(s)
6th Jun 201910:50 amRNSNet Asset Value(s)
5th Jun 20195:18 pmRNSMonth End Net Asset Values
5th Jun 201910:37 amRNSNet Asset Value(s)
4th Jun 201911:00 amRNSNet Asset Value(s)
31st May 201910:28 amRNSNet Asset Value(s)
30th May 20199:51 amRNSNet Asset Value(s)
29th May 20199:51 amRNSNet Asset Value(s)
28th May 201911:06 amRNSNet Asset Value(s)
24th May 201910:06 amRNSNet Asset Value(s)
23rd May 20199:59 amRNSNet Asset Value(s)
22nd May 20199:33 amRNSNet Asset Value(s)
21st May 20199:11 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.